These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Ischemic strokes arriving too late for tPA are an ideal and ethical control group for continuing studies of tPA efficacy. Robinson L Stroke; 1998 Jul; 29(7):1476-7. PubMed ID: 9660407 [No Abstract] [Full Text] [Related]
13. Recombinant tissue plasminogen activator: in my community hospital ED, will early administration of rt-PA to patients with the initial diagnosis of acute ischemic stroke reduce mortality and disability? Wyer PC; Osborn HH Ann Emerg Med; 1997 Nov; 30(5):629-38. PubMed ID: 9360575 [No Abstract] [Full Text] [Related]
17. Neuroradiologists intervene with new therapy for stroke. Sandrick K Diagn Imaging (San Franc); 1999 Jan; 21(1):19-20. PubMed ID: 11692376 [No Abstract] [Full Text] [Related]
18. Thrombolysis with tissue plasminogen activator: protocol violation is not an option. Kumar S Neurol India; 2007; 55(2):174; author reply 174-5. PubMed ID: 17558129 [No Abstract] [Full Text] [Related]
19. Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke. Mann J Stroke; 2005 May; 36(5):929; author reply 929. PubMed ID: 15867164 [No Abstract] [Full Text] [Related]
20. Efficacy and safety of i.v. alteplase therapy up to 4.5 hours after acute ischemic stroke onset. Otwell JL; Phillippe HM; Dixon KS Am J Health Syst Pharm; 2010 Jul; 67(13):1070-4. PubMed ID: 20554592 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]